Cargando…
Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction
BACKGROUND: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Up to 20%–30% of patients hospitalized with COVID-19 have evidence of cardiac dysfunction. Xuebijing injection is a compound injection containing...
Autores principales: | He, Ding-Dong, Zhang, Xiao-Kang, Zhu, Xin-Yu, Huang, Fang-Fang, Wang, Zi, Tu, Jian-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899014/ https://www.ncbi.nlm.nih.gov/pubmed/33662681 http://dx.doi.org/10.1016/j.compbiomed.2021.104293 |
Ejemplares similares
-
Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology
por: Zheng, Wen-jiang, et al.
Publicado: (2020) -
Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network pharmacology and molecular docking
por: Tianyu, Zhao, et al.
Publicado: (2021) -
Analysis of the Efficacy and Mechanism of Action of Xuebijing Injection on ARDS Using Meta-Analysis and Network Pharmacology
por: Zhang, Yun, et al.
Publicado: (2021) -
Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019
por: XING, Yan, et al.
Publicado: (2020) -
Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production
por: Wang, Xin-Tong, et al.
Publicado: (2021)